Serum levels of bone cytokines are increased in indolent systemic mastocytosis associated with osteopenia or osteoporosis - 01/08/13

Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
This work was supported by research grants from the German Research Council (DFG; CRC/SFB832, project A14), the German-Israeli Foundation for Scientific Research and Development (993/2008), and the Wilhelm Sander Foundation (1999.049.2) to K.H. |
|
Disclosure of potential conflict of interest: K. Hartmann is a consultant in a Novartis clinical trial on mastocytosis; is (or recently was) a speaker for ALK-Abelló, Novartis, and Shire; and received research grants from Novartis. The rest of the authors declare that they have no relevant conflicts of interest. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?